251 related articles for article (PubMed ID: 8750016)
1. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
Mandelboim O; Vadai E; Feldman M; Eisenbach L
Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
[TBL] [Abstract][Full Text] [Related]
2. H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire.
Mandelboim O; Feldman M; Eisenbach L
J Immunol; 1992 Jun; 148(11):3666-73. PubMed ID: 1588053
[TBL] [Abstract][Full Text] [Related]
3. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
4. MHC class I genes controlling the metastatic phenotype of tumor cells.
Feldman M; Eisenbach L
Semin Cancer Biol; 1991 Oct; 2(5):337-46. PubMed ID: 1773049
[TBL] [Abstract][Full Text] [Related]
5. Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogeneic class I major histocompatibility complex gene (H-2Ld).
Itaya T; Yamagiwa S; Okada F; Oikawa T; Kuzumaki N; Takeichi N; Hosokawa M; Kobayashi H
Cancer Res; 1987 Jun; 47(12):3136-40. PubMed ID: 3107804
[TBL] [Abstract][Full Text] [Related]
6. c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.
Yamit-Hezi A; Plaksin D; Eisenbach L
Oncogene; 1994 Apr; 9(4):1065-79. PubMed ID: 8134110
[TBL] [Abstract][Full Text] [Related]
7. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
[TBL] [Abstract][Full Text] [Related]
8. Abolishment of metastasis formation by murine tumor cells transfected with "foreign" H-2K genes.
Gelber C; Plaksin D; Vadai E; Feldman M; Eisenbach L
Cancer Res; 1989 May; 49(9):2366-73. PubMed ID: 2784997
[TBL] [Abstract][Full Text] [Related]
9. The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells.
Eisenbach L; Hollander N; Greenfeld L; Yakor H; Segal S; Feldman M
Int J Cancer; 1984 Oct; 34(4):567-73. PubMed ID: 6490207
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells.
Porgador A; Tzehoval E; Katz A; Vadai E; Revel M; Feldman M; Eisenbach L
Cancer Res; 1992 Jul; 52(13):3679-86. PubMed ID: 1617640
[TBL] [Abstract][Full Text] [Related]
11. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
Gorelik E; Jay G; Kwiatkowski B; Herberman RB
J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
[TBL] [Abstract][Full Text] [Related]
12. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
Hui KM; Sim T; Foo TT; Oei AA
J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720
[TBL] [Abstract][Full Text] [Related]
13. Influence on metastasis of the reduction of major histocompatibility complex (MHC) class I gene with an antisense oligonucleotide.
Kanbe M; Arita D; Satoh T; Yokoyama A; Murakawa Y; Kikuchi H; Kanamaru R
Anticancer Drug Des; 1992 Aug; 7(4):341-50. PubMed ID: 1510801
[TBL] [Abstract][Full Text] [Related]
14. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
[TBL] [Abstract][Full Text] [Related]
15. Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine.
Gorelik E; Peppoloni S; Overton R; Herberman RB
Cancer Res; 1985 Nov; 45(11 Pt 1):5341-7. PubMed ID: 2413992
[TBL] [Abstract][Full Text] [Related]
16. Loss of the H-2.33 private specificity by 3LL tumor cells correlates with the tumor potential to metastasize across the H-2K region genetic barriers.
Isakov N; Feldman M; Segal S
Exp Clin Immunogenet; 1984; 1(3):170-4. PubMed ID: 6401004
[TBL] [Abstract][Full Text] [Related]
17. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
Isakov N; Feldman M; Segal S
J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
[TBL] [Abstract][Full Text] [Related]
18. Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from nonmetastatic to metastatic cells.
Katzav S; De Baetselier P; Tartakovsky B; Feldman M; Segal S
J Natl Cancer Inst; 1983 Aug; 71(2):317-24. PubMed ID: 6576189
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Li M; Muller J; Xu F; Hearing VJ; Gorelik E
Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
[TBL] [Abstract][Full Text] [Related]
20. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
Isakov N; Feldman M; Segal S
Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
